Evidence map›Paper›PMID 39203435›Full record

ArticleMicroorganisms2024

Multidisciplinary Effort Leading to Effective Tuberculosis Community Outbreak Containment in Israel.

Inbal Fuchs, Yelena Losev, Zohar Mor, Mor Rubinstein, Marina Polyakov, Tali Wagner, Tamar Gobay, Ester Bayene, Gila Mula, Hasia Kaidar-Shwartz and 4 more

Abstract read
In one paragraph

Article in Microorganisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Inbal FuchsClalit Health Services, Central District, Rishon LeTsiyon 7528809, Israel.
Yelena LosevNational Mycobacterium Reference Center, Ministry of Health, Tel Aviv 6810416, Israel.
Zohar MorDepartment of Tuberculosis and AIDS, Ministry of Health, Jerusalem 9438317, Israel.
Mor RubinsteinNational Public Health Laboratories, Ministry of Health, Tel Aviv 6810416, Israel.
Marina PolyakovCentral District Department of Health, Ministry of Health, Ramla 7243003, Israel.
Tali WagnerDepartment of Tuberculosis and AIDS, Ministry of Health, Jerusalem 9438317, Israel.
Tamar GobayCentral District Department of Health, Ministry of Health, Ramla 7243003, Israel.
Ester BayeneClalit Health Services, Central District, Rishon LeTsiyon 7528809, Israel.
Gila MulaClalit Health Services, Central District, Rishon LeTsiyon 7528809, Israel.
Hasia Kaidar-ShwartzNational Mycobacterium Reference Center, Ministry of Health, Tel Aviv 6810416, Israel.
Zeev DveyrinNational Public Health Laboratories, Ministry of Health, Tel Aviv 6810416, Israel.ORCID 0000-0003-1210-7342
Efrat RormanMinistry of Health Laboratories Department, Ministry of Health, Jerusalem 9134302, Israel.ORCID 0000-0001-6796-4726
Ehud KalinerCentral District Department of Health, Ministry of Health, Ramla 7243003, Israel.
Sivan Haia PerlDepartment of Tuberculosis and AIDS, Ministry of Health, Jerusalem 9438317, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis (TB) is the second-most prevalent cause of mortality resulting from infectious diseases worldwide. It is caused by bacteria belonging to the Mycobacterium tuberculosis complex (MTBC). In Israel, TB incidence is low, acknowledged by the WHO as being in a pre-elimination phase. Most cases occur among immigrants from high TB incidence regions like the Horn of Africa and the former Soviet Union (FSU), with occasional outbreaks. The outbreak described in this report occurred between 2018 and 2024, increasing the incidence rate of TB in the region. Control of this outbreak posed challenges due to factors including a diverse population (including Ethiopian immigrants, Israeli-born citizens, and immigrants from other countries), economic and social barriers, and hesitancy to disclose information. The unique multidisciplinary team formed to address these challenges, involving the local TB clinic, district health ministry, health maintenance organization (HMO) infectious disease consultant, neighborhood clinic, and National Mycobacterium Reference Laboratory (NMRL), achieved effective treatment and containment. Whole genome sequencing (WGS) proved pivotal in unraveling patient connections during the outbreak. It pinpointed those patients overlooked in initial field investigations, established connections between patients across different health departments, and uncovered the existence of two distinct clusters with separate transmission chains within the same neighborhood. This study underscores collaborative efforts across sectors that successfully contained a challenging outbreak.

Indexed as

epidemiological investigationIsraeloutbreaktuberculosiswhole genome sequencing

Identifiers

PMID39203435
PMCPMC11356750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.